Activation of a 66-kilodalton human endothelial cell matrix metalloprotease by Streptococcus pyogenes extracellular cysteine protease

Human umbilical vein endothelial cells (HUVECs) were used to gain insight into the molecular mechanism whereby the major extracellular protease from group A streptococci damages host tissue. HUVECs exposed to streptococcal cysteine protease (SCP) for various times exhibited cytopathic effect and cell detachment from the culture vessel. Gelatin substrate zymography showed that a time- and concentration-dependent increase in the level of activity of an approximately 66-kDa gelatinase occurred in culture medium taken from cells exposed to enzymatically active SCP. This gelatinase comigrated in gelatin zymograms with the activated form of purified recombinant matrix metalloprotease 2 (MMP-2) and had type IV collagenase activity. In contrast, medium taken from cells exposed to inactivated (boiled) SCP and cells exposed to SCP inhibited by treatment with N-benzyloxycarbonyl-leucyl-valyl-glycine diazomethyl ketone lacked the 66-kDa gelatinase. Appearance of the 66-kDa gelatinase activity was also prevented by 1,10-phenanthroline, a zinc chelator and MMP inhibitor. Inasmuch as proteolytically active SCP is required for the emergence of this gelatinase and MMP activation occurs by proteolytic processing, the 66-kDa gelatinase may be a proteolytic cleavage product of a latent MMP expressed extracellularly by HUVECs. Direct SCP treatment of culture supernatant taken from HUVECs not exposed to SCP also produced the 66-kDa gelatinase. The data show that SCP activates an MMP produced by human endothelial cells, a process that may contribute to endothelial cell damage, tissue destruction, and hemodynamic derangement observed in some patients with severe, invasive group A streptococcal infection.

[1]  J. Musser.  Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function. , 1997, Preparative biochemistry & biotechnology.

[2]  S. Holm.  Invasive group A streptococcal infections. , 1996, The New England journal of medicine.

[3]  J. Musser,et al.  Streptococcal cysteine protease augments lung injury induced by products of group A streptococci , 1996, Infection and immunity.

[4]  D. Stevens,et al.  Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. , 1996, The Journal of infectious diseases.

[5]  W. Rom,et al.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. , 1996, Thorax.

[6]  L. Cornelius,et al.  Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. , 1995, The Journal of investigative dermatology.

[7]  J. Foidart,et al.  Matrix metalloproteinase family. , 1995, Cell biology international.

[8]  F. Breedveld,et al.  Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. , 1995, The Journal of rheumatology.

[9]  A. Norrby-Teglund,et al.  Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. , 1995, Scandinavian journal of infectious diseases.

[10]  W. Stetler-Stevenson,et al.  The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. , 1994, The European respiratory journal.

[11]  D. Sexton,et al.  Necrotizing fasciitis and myositis caused by group A streptococci. Epidemiology, diagnosis, and treatment of "flesh-eating bacteria". , 1994, North Carolina medical journal.

[12]  J. O'Connell,et al.  Regulation of Matrix Metalloproteinase Activity a , 1994, Annals of the New York Academy of Sciences.

[13]  A. H. Drummond,et al.  Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.

[14]  J. Musser,et al.  Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. , 1994, Microbial pathogenesis.

[15]  M A Moses,et al.  Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.

[16]  W. Stetler-Stevenson,et al.  Quantitative zymography: detection of picogram quantities of gelatinases. , 1994, Analytical biochemistry.

[17]  R. Poorman,et al.  Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.

[18]  G. Payonk,et al.  Treating periodontal diseases by blocking tissue-destructive enzymes. , 1994, Journal of the American Dental Association.

[19]  W. Dunne,et al.  Fatal group A streptococcal meningitis and toxic shock-like syndrome: case report. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  V. V. van Hinsbergh,et al.  Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.

[21]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[22]  N. Lang,et al.  Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. , 1993, Journal of periodontal research.

[23]  H. Birkedal‐Hansen.  Role of cytokines and inflammatory mediators in tissue destruction. , 1993, Journal of periodontal research.

[24]  W. Stetler-Stevenson,et al.  Structural biochemistry and activation of matrix metalloproteases. , 1993, Current opinion in cell biology.

[25]  J. Musser,et al.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Schnaper,et al.  Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro , 1993, Journal of cellular physiology.

[27]  K. Kenyon,et al.  Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. , 1993, Investigative ophthalmology & visual science.

[28]  B. Congeni.  The resurgence of acute rheumatic fever in the United States. , 1992, Pediatric annals.

[29]  K. Kenyon,et al.  Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. , 1992, Current eye research.

[30]  Y. Konttinen,et al.  Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases , 1992, Infection and immunity.

[31]  S. Holm,et al.  Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.

[32]  Y. Kato,et al.  Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. , 1992, The Journal of biological chemistry.

[33]  U. Thorgeirsson,et al.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.

[34]  E. Kaplan,et al.  Association of exotoxin-producing group A streptococci and severe disease in children. , 1991, The Pediatric infectious disease journal.

[35]  C. Prinz,et al.  Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de‐endothelialization and repair , 1991, Journal of cellular biochemistry.

[36]  D. Carey,et al.  Control of growth and differentiation of vascular cells by extracellular matrix proteins. , 1991, Annual review of physiology.

[37]  P. Schlievert,et al.  Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor , 1990, Journal of bacteriology.

[38]  H. Birkedal‐Hansen,et al.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Z. Werb,et al.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.

[40]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[41]  H. Knöll,et al.  Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. , 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[42]  K M Yamada,et al.  Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.

[43]  B. Agarwal.  RHEUMATIC HEART DISEASE UNABATED IN DEVELOPING COUNTRIES , 1981, The Lancet.

[44]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[45]  J. Musser.  Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by Streptococcus pyogenes. Structure and function. , 1997, Preparative biochemistry & biotechnology.

[46]  W. Rom,et al.  Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. , 1996, Thorax.

[47]  J. Musser,et al.  Streptococcal cysteine protease augments lung injury induced by products of group A streptococci , 1996, Infection and immunity.

[48]  D. Stevens,et al.  Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. , 1996, The Journal of infectious diseases.

[49]  L. Cornelius,et al.  Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. , 1995, The Journal of investigative dermatology.

[50]  J. Foidart,et al.  Matrix metalloproteinase family. , 1995, Cell biology international.

[51]  F. Breedveld,et al.  Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. , 1995, The Journal of rheumatology.

[52]  A. Norrby-Teglund,et al.  Correlation between serum TNF alpha and IL6 levels and severity of group A streptococcal infections. , 1995, Scandinavian journal of infectious diseases.

[53]  W. Stetler-Stevenson,et al.  The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. , 1994, The European respiratory journal.

[54]  D. Sexton,et al.  Necrotizing fasciitis and myositis caused by group A streptococci. Epidemiology, diagnosis, and treatment of "flesh-eating bacteria". , 1994, North Carolina medical journal.

[55]  J. O'Connell,et al.  Regulation of Matrix Metalloproteinase Activity a , 1994, Annals of the New York Academy of Sciences.

[56]  A. H. Drummond,et al.  Processing of tumour necrosis factor-α precursor by metalloproteinases , 1994, Nature.

[57]  J. Musser,et al.  Vaccination with streptococcal extracellular cysteine protease (interleukin-1 beta convertase) protects mice against challenge with heterologous group A streptococci. , 1994, Microbial pathogenesis.

[58]  M A Moses,et al.  Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). , 1994, The Journal of biological chemistry.

[59]  W. Stetler-Stevenson,et al.  Quantitative zymography: detection of picogram quantities of gelatinases. , 1994, Analytical biochemistry.

[60]  R. Poorman,et al.  Interstitial collagenase is required for angiogenesis in vitro. , 1994, Developmental biology.

[61]  G. Payonk,et al.  Treating periodontal diseases by blocking tissue-destructive enzymes. , 1994, Journal of the American Dental Association.

[62]  W. Dunne,et al.  Fatal group A streptococcal meningitis and toxic shock-like syndrome: case report. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[63]  V. V. van Hinsbergh,et al.  Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. , 1993, The Biochemical journal.

[64]  J. Musser,et al.  A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. , 1993, Microbial pathogenesis.

[65]  N. Lang,et al.  Detection of interleukin-8 and matrix metalloproteinases transcripts in healthy and diseased gingival biopsies by RNA/PCR. , 1993, Journal of periodontal research.

[66]  H. Birkedal‐Hansen.  Role of cytokines and inflammatory mediators in tissue destruction. , 1993, Journal of periodontal research.

[67]  W. Stetler-Stevenson,et al.  Structural biochemistry and activation of matrix metalloproteases. , 1993, Current opinion in cell biology.

[68]  J. Musser,et al.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[69]  H. Schnaper,et al.  Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro , 1993, Journal of cellular physiology.

[70]  K. Kenyon,et al.  Cleavage and activation of corneal matrix metalloproteases by Pseudomonas aeruginosa proteases. , 1993, Investigative ophthalmology & visual science.

[71]  B. Congeni.  The resurgence of acute rheumatic fever in the United States. , 1992, Pediatric annals.

[72]  K. Kenyon,et al.  Proteolytic activation of corneal matrix metalloproteinase by Pseudomonas aeruginosa elastase. , 1992, Current eye research.

[73]  Y. Konttinen,et al.  Identification of proteases from periodontopathogenic bacteria as activators of latent human neutrophil and fibroblast-type interstitial collagenases , 1992, Infection and immunity.

[74]  S. Holm,et al.  Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.

[75]  Y. Kato,et al.  Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. , 1992, The Journal of biological chemistry.

[76]  E. Kaplan,et al.  Invasive group A streptococcal infections. , 1992, Infectious disease clinics of North America.

[77]  U. Thorgeirsson,et al.  Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. , 1992, Invasion & metastasis.

[78]  E. Kaplan,et al.  Association of exotoxin-producing group A streptococci and severe disease in children. , 1991, The Pediatric infectious disease journal.

[79]  C. Prinz,et al.  Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: Models of de‐endothelialization and repair , 1991, Journal of cellular biochemistry.

[80]  Z. Werb,et al.  Extracellular Matrix Degradation , 1991 .

[81]  D. Carey,et al.  Control of growth and differentiation of vascular cells by extracellular matrix proteins. , 1991, Annual review of physiology.

[82]  P. Schlievert,et al.  Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor , 1990, Journal of bacteriology.

[83]  H. Birkedal‐Hansen,et al.  Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[84]  Z. Werb,et al.  Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression , 1989, The Journal of cell biology.

[85]  H. Kleinman,et al.  Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures , 1988, The Journal of cell biology.

[86]  H. Knöll,et al.  Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. , 1983, Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene. 1. Abt. Originale A, Medizinische Mikrobiologie, Infektionskrankheiten und Parasitologie = International journal of microbiology and hygiene. A, Medical microbiology, infectious....

[87]  K M Yamada,et al.  Cell surface interactions with extracellular materials. , 1983, Annual review of biochemistry.

[88]  B. Agarwal.  RHEUMATIC HEART DISEASE UNABATED IN DEVELOPING COUNTRIES , 1981, The Lancet.

[89]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.